您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Enavogliflozin
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Enavogliflozin
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Enavogliflozin图片
CAS NO:1415472-28-4
包装与价格:
包装价格(元)
5mg电议
10mg电议

产品介绍
Enavogliflozin (DWP-16001) 作为一种抗糖尿病药物,是一种具有口服活性,一流的选择性钠-葡萄糖协同转运体 -2 (SGLT-2) 抑制剂。
Cas No.1415472-28-4
别名DWP-16001
分子式C24H27ClO6
分子量446.92
溶解度DMSO : 100 mg/mL (223.75 mM; Need ultrasonic)
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Enavogliflozin (DWP-16001), an antidiabetic agent, is an orally active, best-in-class and selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor[1][2][3].

Enavogliflozin (DWP-16001), an antidiabetic agent, is an orally active, best-in-class and selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor[1][2][3].

[1]. Daewoong speeds up developing antidiabetic Enavogliflozin
[2]. These are the results of clinical trials of the diabetes drug Enavogliflozin and Metformin
[3]. Global Diabetes Pipeline Landscape Report 2020 Featuring Daewoong’s Enavogliflozin & Janssen Biotech’s Golimumab Among Others - ResearchAndMarkets.com